BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8468523)

  • 1. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).
    Harwood HJ; Chandler CE; Pellarin LD; Bangerter FW; Wilkins RW; Long CA; Cosgrove PG; Malinow MR; Marzetta CA; Pettini JL
    J Lipid Res; 1993 Mar; 34(3):377-95. PubMed ID: 8468523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting cholesterol absorption with CP-88,818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects.
    Harris WS; Dujovne CA; Windsor SL; Gerrond LL; Newton FA; Gelfand RA
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):55-60. PubMed ID: 9268221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action.
    Morehouse LA; Bangerter FW; DeNinno MP; Inskeep PB; McCarthy PA; Pettini JL; Savoy YE; Sugarman ED; Wilkins RW; Wilson TC; Woody HA; Zaccaro LM; Chandler CE
    J Lipid Res; 1999 Mar; 40(3):464-74. PubMed ID: 10064735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
    Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
    Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS).
    Wilson TA; Nicolosi RJ; Rogers EJ; Sacchiero R; Goldberg DJ
    Atherosclerosis; 1998 Oct; 140(2):315-24. PubMed ID: 9862274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant stanol fatty acid esters inhibit cholesterol absorption and hepatic hydroxymethyl glutaryl coenzyme A reductase activity to reduce plasma levels in rabbits.
    Xu G; Salen G; Shefer S; Tint GS; Nguyen LB; Batta AK; Pcolinsky M
    Metabolism; 2001 Sep; 50(9):1106-12. PubMed ID: 11555847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of total hepatic low density lipoprotein receptor levels in the hamster.
    Cosgrove PG; Gaynor BJ; Harwood HJ
    J Lipid Res; 1993 Nov; 34(11):1983-2003. PubMed ID: 8263422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
    Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.
    Murakami S; Kondo Y; Toda Y; Kitajima H; Kameo K; Sakono M; Fukuda N
    Life Sci; 2002 Apr; 70(20):2355-66. PubMed ID: 12150200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
    Benson GM; Alston DR; Bond BC; Gee AN; Glen A; Haynes C; Hickey DM; Iqbal S; Jackson B; Jaxa-Chamiec AA
    Atherosclerosis; 1993 Jun; 101(1):51-60. PubMed ID: 8216502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol lowering action of HOE 402 in the normolipidemic and hypercholesterolemic golden Syrian hamster.
    Hoffmann A; Schmalz M; Leineweber M
    Biochim Biophys Acta; 1996 Jan; 1299(1):95-102. PubMed ID: 8555258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus polysaccharides lowers plasma cholesterol through mechanisms distinct from statins.
    Cheng Y; Tang K; Wu S; Liu L; Qiang C; Lin X; Liu B
    PLoS One; 2011; 6(11):e27437. PubMed ID: 22110652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tiqueside (beta-tigogenin cellobioside) in dogs, rats, rabbits, and monkeys.
    Inskeep PB; Connolly AG; Cole MJ; Luther EW; Biehl ML; Marzetta CA; Savoy YE; Silber BM
    J Pharm Sci; 1995 Jan; 84(1):12-4. PubMed ID: 7714734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
    Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
    J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys.
    Marzetta CA; Savoy YE; Freeman AM; Long CA; Pettini JL; Hagar RE; Inskeep PB; Davis K; Stucchi AF; Nicolosi RJ
    J Lipid Res; 1994 Oct; 35(10):1829-38. PubMed ID: 7852860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocholesterolemic effect of physically refined rice bran oil: studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters.
    Ausman LM; Rong N; Nicolosi RJ
    J Nutr Biochem; 2005 Sep; 16(9):521-9. PubMed ID: 16115540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic low density lipoprotein receptors, HMG-CoA reductase, and plasma lipids and apolipoproteins in high- and low-responding rhesus monkeys: effect of cholestyramine treatment.
    Dory L; Bhattacharyya A; Strong J; Chappuis C
    J Lipid Res; 1990 Feb; 31(2):279-87. PubMed ID: 2324647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol, bile acid, and lipoprotein metabolism in two strains of hamster, one resistant, the other sensitive (LPN) to sucrose-induced cholelithiasis.
    Férézou J; Combettes-Souverain M; Souidi M; Smith JL; Boehler N; Milliat F; Eckhardt E; Blanchard G; Riottot M; Sérougne C; Lutton C
    J Lipid Res; 2000 Dec; 41(12):2042-54. PubMed ID: 11108738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.